Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-12-31

FDA Approved: EXTENDED PHENYTOIN SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for an extended-release formulation of phenytoin sodium by Amneal Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Extended Phenytoin Sodium (phenytoin sodium)

Snippet

SUPPL AP for EXTENDED PHENYTOIN SODIUM (PHENYTOIN SODIUM)